 |
 |
| Hurst, James |
|
| Ulrich, Lynn |
|
| Pflug, Ashlea |
|
| Blackman, Scott |
|
| Wong, Jovial |
|
| Standish, Gail |
|
| Perkowski, Peter |
|
| Shin, Howard |
|
| Samay, Scott |
|
| Nomura, Ian |
|
| Yanniello, Ian |
|
|
 |
|
| Intellectual Property |
|
| Patent Litigation |
|
| Litigation |
|
|
|
|
| Sun Pharmaceuticals, Inc. v. Eli Lilly, Co. |
|
Sun Pharmaceutical Industries, Ltd.
|
|
|
|
| In a case that garnered national press attention, Winston & Strawn defeated a patent covering one of Eli Lilly & Co.’s leading cancer drugs. On behalf of client Sun Pharmaceutical Industries, Winston asserted that Lilly engaged in improper double patenting to protect Gemzar®, a blockbuster drug with annual sales exceeding $2 billion per year. Both the district court and the Federal Circuit agreed with Winston and invalidated the offending patent, which will allow generic competition to Gemzar® two-and-a-half years early. |
|
|
Select A Region
Search for an attorney.
